1. Abdullah-Koolmees, H, Gardarsdottir, H, Minnema, LA, et al Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study. Ther Adv Psychopharmacol 2018; 8: 213–229.
Google Scholar | SAGE Journals | ISI2. Fenton, WS, Blyler, CR, Heinssen, RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23: 637–651.
Google Scholar | Crossref | Medline | ISI3. Kuwabara, H, Saito, Y, Mahlich, J. Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data. Neuropsychiatr Dis Treat 2015; 11: 935–940.
Google Scholar | Medline4. Hui, CLM, Chen, EYH, Kan, CS, et al Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong. Keio J Med 2006; 55: 9–14.
Google Scholar | Crossref | Medline5. Simpson, SH, Eurich, DT, Majumdar, SR, et al A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
Google Scholar | Crossref | Medline6. Kaleva, V . Adherence to medication. Pediatriya 2015; 55: 68–69.
Google Scholar7. Lee, SY, Kim, KH, Kim, T, et al Outpatient follow-up visit after hospital discharge lowers risk of rehospitalization in patients with schizophrenia: a nationwide population-based study. Psychiatry Investig 2015; 12: 425–433.
Google Scholar | Crossref | Medline8. Lehman, AF, Lieberman, JA, Dixon, LB, et al Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004; 161(2 Suppl): 1–56.
Google Scholar | Medline | ISI9. Tiihonen, J, Haukka, J, Taylor, M, et al A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011; 168: 603–609.
Google Scholar | Crossref | Medline | ISI10. Tiihonen, J, Taipale, H, Mehtälä, J, et al Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia. JAMA Psychiatry 2019; 76: 499–507.
Google Scholar | Crossref | Medline11. WHO . Guidelines for and DDD assignment. Oslo, Norway: WHO Collaborating Centre, 2013, pp.1–284.
Google Scholar12. Weiden, PJ, Kozma, C, Grogg, A, et al Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia. Psychiatr Serv 2004; 55: 886–891.
Google Scholar | Crossref | Medline | ISI13. Hugenholtz, GWK, Stolker, JJ, Heerdink, ER, et al Short-acting parenteral antipsychotics drive choice for classical versus atypical agents. Eur J Clin Pharmacol 2003; 58: 757–760.
Google Scholar | Crossref | Medline14. Gorwood, P . Factors associated with hospitalisation of patients with schizophrenia in four European countries. Eur Psychiatry 2011; 26: 224–230.
Google Scholar | Crossref | Medline15. Olfson, M, Mechanic, D, Hansell, S, et al Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000; 51: 216–222.
Google Scholar | Crossref | Medline | ISI16. Reutfors, J, Brandt, L, Stephansson, O, et al Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder. J Clin Psychopharmacol 2013; 33: 759–765.
Google Scholar | Crossref | Medline17. Gardarsdottir, H, Souverein, PC, Egberts, TCG, et al Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol 2010; 63: 422–427.
Google Scholar | Crossref | Medline | ISI18. Zilber, N, Hornik-Lurie, T, Lerner, Y. Predictors of early psychiatric rehospitalization: a national case register study. Isr J Psychiatry Relat Sci 2011; 48: 49–53.
Google Scholar | Medline19. Laan, W, Van Der Does, Y, Sezgi, B, et al Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge. Pharmacopsychiatry 2010; 43: 221–224.
Google Scholar | Crossref | Medline | ISI20. Taylor, M, Jauhar, S. Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia. Ther Adv Psychopharmacol 2019; 9: 204512531987003.
Google Scholar | SAGE Journals21. Law, MR, Soumerai, SB, Ross-Degnan, D, et al A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry 2008; 69: 47–53.
Google Scholar | Crossref | Medline | ISI22. Department of Health . Psychosis and schizophrenia in adults: treatment and management. Feb 54 Clinical Guidelines No. 178, NICE, 2014. London, UK.
Google Scholar23. De Geest, S, Zullig, LL, Dunbar-Jacob, J, et al ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med 2018; 169: 30–35.
Google Scholar | Crossref | Medline24. Vrijens, B, De Geest, S, Hughes, DA, et al A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691–705.
Google Scholar | Crossref | Medline | ISI25. Boden, R, Brandt, L, Kieler, H, et al. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Res 2011; 133(1-3): 36–41.
Google Scholar | Crossref | Medline26. Daliri, S, Hugtenburg, JG, Ter Riet, G, et al The effect of a pharmacy-led transitional care program on medication-related problems post-discharge: a before-after prospective study. PLoS One 2019; 14: e0213593.
Google Scholar | Crossref | Medline27. El Morabet, N, Uitvlugt, EB, van den Bemt, BJF, et al Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc 2018; 66: 602–608.
Google Scholar | Crossref | Medline28. Uitvlugt, EB, Suijker, R, Janssen, MJA, et al Quality of medication related information in discharge letters: a prospective cohort study. Eur J Intern Med 2017; 46: e23–e25.
Google Scholar | Crossref | Medline